Impact of patent (Amendment) act, 2005 on Indian pharmaceutical industry with reference to R&D expenditure, profit, export and sales
Keywords:
Indian pharmaceutical industry, R&D expenditure, profitAbstract
The Indian pharmaceutical business is the world's third-largest pharmaceutical sector in terms of volume, but it ranks 14th in terms of value. The lower position in terms of value might be due to the fact that Indian pharmaceutical enterprises are mostly focused on low-cost generic pharmaceuticals, with a broad range of company sizes and product mix. Because of Trade Related Intellectual Property Rights (TRIPS) restrictions, the Indian pharmaceutical business has undergone significant transformation since 1995. TRIPS ratification has had a considerable effect on Indian pharmaceutical industries. The effect of TRIPS on the Indian pharmaceutical industry’s R&D Expenditure, profit, export and sales is examined using a dummy variable in this research. Various industrial performance drivers, such as knowledge-based resources and property-based resources, are considered. The research considers a sample of 25 Indian pharmaceutical enterprises over a twenty-five year period (1996-2020). The results show that the Indian pharmaceutical industry is significantly impacted by TRIPS compliance. The findings of this study also emphasize the relative impact of various company resources on the performance of Indian pharmaceutical enterprises.
Downloads
References
Allugunti, V.R. (2019). Diabetes Kaggle Dataset Adequacy Scrutiny using Factor Exploration and Correlation. International Journal of Recent Technology and Engineering, Volume-8, Issue-1S4, pp 1105-1110.
Aulakh, P. S., & Kotabe, M. (2008). Institutional changes and organizational transformation in developing economies. Journal of International Management, 14 (3), 209–216. doi:10.1016/j.intman.2008.04.001
Baltagi, B. H. (2008). Econometric analysis of panel data (Vol. 4). Chichester: John wiley & sons.
Bhatt, S., and Panigrahi, A. (2014). Impact of Recession on Indian Pharma Sector. International Journal of Research in Commerce, Economics and Management, 4(11).
Bruton, G. D., Ahlstrom, D., & Puky, T. (2009). Institutional differences and the development of entrepreneurial ventures: A comparison of the venture capital industries in Latin America and Asia. Journal of International Business Studies, 40 (5), 762–778.
Chari, M. D. R., & Banalieva, E. R. (2015). How do pro-market reforms impact firm profitability? The case of India under reform. Journal of World Business, 50 (2), 357–367.
Cuervo-Cazurra, A., & Dau, L. A. (2009). Pro-market reforms and firm profitability in developing countries. Academy of Management Journal, 52 (6), 1348–1368.
Department of Pharmaceuticals. (2019). 2019-2020 Annual Report. Government of India, Ministry of Chemicals and Fertilizers.
Ettlie JE (1998) R&D and global manufacturing performance. Manag Sci 44(1):1–11 Bhagwat Y, DeBruine M (2011) R&D and advertising efficiencies in the pharmaceutical industry. Int J Appl Econ 8(1):55–65
FA: Hersh F. Mahmood, Hooshang Dabbagh, Azad A. Mohammed, Comparative study on using chemical and natural admixtures (grape and mulberry extracts) for concrete, Case Studies in Construction Materials, Volume 15, 2021,
Government of India, Ministry of Commerce & Industry. (2020). PIB. Retrieved from https://pib.gov. in/PressReleasePage.aspx?PRID=1624102#:~:text=India’s%20overall%20exports%20(Merchandise%20 and,the%20same%20period%20last%20year.
Govindaraj, R. and Chellaraj, G. (2002), The Indian Pharmaceutical Sector: Issues and Options for Health Sector Reform, World Bank Publications.
Greene, W. H. (2003). Econometric analysis. Pearson Education India.
Gujarati, D. N. (2009). Basic Econometrics (5th Ed.). McGraw Hill Inc., New York.
Gupta, R., & Manchikanti, P. (2010). Analysis of patenting trends of antifungal drugs in the product patent regime in India. World Patent Information, 32 (2), 135-140. doi: 10.1016/j.wpi.2009.05.002
Hair, J. F., Jr., Anderson, R. E., Tatham, R. L. and Black, W. C. (1995) Multivariate Data Analysis, 3rd ed, Macmillan Publishing Company, New York.
IBEF. Pharmaceuticals. Retrieved from IBEF: https:// www.ibef.org/archives
India, Pharmaceuticals Export Promotion Council of India (pharmexcil). (2018). 15th Annual Report. Ministry of Commerce & Industry, Government of India.
Katsikeas, C. S., Leonidou, L. C. and Morgan, N. A. (2000). Firm-level export performance assessment: review, evaluation and development. Journal of the Academy of Marketing Science, 28 (4), 493–511.
Kumar, S. (2022). A quest for sustainium (sustainability Premium): review of sustainable bonds. Academy of Accounting and Financial Studies Journal, Vol. 26, no.2, pp. 1-18
Lev B, Sougiannis T (1996) The capitalization, amortization and value-relevance of R&D. J Account Econ 21:107–138.
McKinley, W., Mone, M., & Moon, G. (1999). Determinants and development of schools in organization theory. Academy of Management Review ,24(4), 634–648.
Park, S. H., Li, S., & Tse, D. K. (2006). Market liberalization and firm performance during China’s economic transition. Journal of International Business Studies, 37 (1), 127–147.
Peng, M. (2004).Identifying the big research question in international business. Journal of International Business Studies. 35(2), 99-108.
Rentala, S., Anand, B., & Shaban, M. (2014). Technological capabilities and firm resources as determinants of export competitiveness: Evidence from Indian pharmaceutical industry using quantile regression approach. Journal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 14 (2-3), 133-144.
Tyagi, S. and Nauriyal, D. (2016), “Profitability determinants in Indian drugs and pharmaceutical industry: an analysis of pre and post TRIPS period”, Eurasian Journal of Business and Economics, Vol. 9 No. 17, pp. 1-21.
Uctum, M. (1995) “The evolution and determinants of corporate profits: an international comparison”, Federal Reserve Bank of New York Research Paper, No. 9502.
Wooldridge, J. (2002). Econometric analysis of cross section and panel data (pp. 282–283).
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
